Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond

Schizophr Res. 2024 Jan 29:S0920-9964(24)00035-5. doi: 10.1016/j.schres.2024.01.035. Online ahead of print.
No abstract available

Keywords: Agranulocytosis; Clozapine; Psychopharmacology; Therapeutic drug monitoring; Treatment-resistant schizophrenia.